120 related articles for article (PubMed ID: 38110353)
1. Development of Integrated Bioorthogonal Self-Catalyzed NO Donor/Platinum(IV) Prodrugs for Synergistical Intervention against Triple-Negative Breast Cancer.
Zhang C; Zhu J; Yuan X; Yan Z; Ye H; Xiong T; Xu A; Li C; Ji D; Yang S; Zhang J; Zhang Y; Wu J; Huang Z
J Med Chem; 2024 Jan; 67(1):479-491. PubMed ID: 38110353
[TBL] [Abstract][Full Text] [Related]
2. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
3. The novel platinum(IV) prodrug with self-assembly property and structure-transformable character against triple-negative breast cancer.
Yang C; Tu K; Gao H; Zhang L; Sun Y; Yang T; Kong L; Ouyang D; Zhang Z
Biomaterials; 2020 Feb; 232():119751. PubMed ID: 31918218
[TBL] [Abstract][Full Text] [Related]
4. A platinum(iv) prodrug to defeat breast cancer through disrupting vasculature and inhibiting metastasis.
Guo Y; Zhang S; Yuan H; Song D; Jin S; Guo Z; Wang X
Dalton Trans; 2019 Mar; 48(11):3571-3575. PubMed ID: 30793153
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Platinum
Liu W; Yu C; Wang M; He Y; Guo Z; He J; Jiang R; Xu Q; Liang J; Wang S
J Med Chem; 2023 Jun; 66(12):8066-8085. PubMed ID: 37306362
[TBL] [Abstract][Full Text] [Related]
6. Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic Chemotherapy.
Date T; Kuche K; Chaudhari D; Ghadi R; Sahel DK; Chitkara D; Jain S
ACS Biomater Sci Eng; 2022 Jun; 8(6):2349-2362. PubMed ID: 35522530
[TBL] [Abstract][Full Text] [Related]
7. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
Wu Y; Zhao D; Shang J; Huang W; Chen Z
Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
[TBL] [Abstract][Full Text] [Related]
8. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
[TBL] [Abstract][Full Text] [Related]
9. Targeting the tumor microenvironment by an enzyme-responsive prodrug of tubulin destabilizer for triple-negative breast cancer therapy with high safety.
Peng Y; Shi Z; Liang Y; Ding K; Wang Y
Eur J Med Chem; 2022 Jun; 236():114344. PubMed ID: 35405397
[TBL] [Abstract][Full Text] [Related]
10. XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer.
Xu S; Sun X; Luo L; Yang Y; Guo Q; Tang S; Jiang Z; Li Y; Han J; Gan W; Yang F; Zhang X; Liu Y; Sun C; He J; Liu M; Zuo D; Zhu W; Wu Y
Biomed Pharmacother; 2022 Nov; 155():113537. PubMed ID: 36113258
[TBL] [Abstract][Full Text] [Related]
11. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer.
Greer YE; Gilbert SF; Gril B; Narwal R; Peacock Brooks DL; Tice DA; Steeg PS; Lipkowitz S
Breast Cancer Res; 2019 Feb; 21(1):27. PubMed ID: 30777098
[TBL] [Abstract][Full Text] [Related]
12. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
13. General Strategy for Integrated Bioorthogonal Prodrugs: Pt(II)-Triggered Depropargylation Enables Controllable Drug Activation
Sun T; Lv T; Wu J; Zhu M; Fei Y; Zhu J; Zhang Y; Huang Z
J Med Chem; 2020 Nov; 63(22):13899-13912. PubMed ID: 33141588
[TBL] [Abstract][Full Text] [Related]
14. New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo.
Song XQ; Ma ZY; Wu YG; Dai ML; Wang DB; Xu JY; Liu Y
Eur J Med Chem; 2019 Apr; 167():377-387. PubMed ID: 30784875
[TBL] [Abstract][Full Text] [Related]
15. pH-Sensitive Shell-Core Platform Block DNA Repair Pathway To Amplify Irreversible DNA Damage of Triple Negative Breast Cancer.
Dong Y; Liao H; Fu H; Yu J; Guo Q; Wang Q; Duan Y
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38417-38428. PubMed ID: 31556584
[TBL] [Abstract][Full Text] [Related]
16. Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment.
Ma ZY; Song XQ; Hu JJ; Wang DB; Ding XJ; Liu RP; Dai ML; Meng FY; Xu JY
Biochem Pharmacol; 2021 Jun; 188():114523. PubMed ID: 33741331
[TBL] [Abstract][Full Text] [Related]
17. A DNA damage nanoamplifier for the chemotherapy of triple-negative breast cancer via DNA damage induction and repair blocking.
Huang Y; Dai X; Guan Z; Liu D; Ren L; Chen M; Zeng Z; Jiang J; Luo Y; He Y; Huang M; Zhao C
Int J Pharm; 2022 Jun; 622():121897. PubMed ID: 35690308
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
19. Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer.
Muhammad N; Tan CP; Nawaz U; Wang J; Wang FX; Nasreen S; Ji LN; Mao ZW
Inorg Chem; 2020 Sep; 59(17):12632-12642. PubMed ID: 32838518
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Characterization of Nitric Oxide-Releasing Platinum(IV) Prodrug and Polymeric Micelle Triggered by Light.
Pramanick S; Kim J; Kim J; Saravanakumar G; Park D; Kim WJ
Bioconjug Chem; 2018 Apr; 29(4):885-897. PubMed ID: 29281788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
